Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

A Clinical Study to Evaluate the Use of a Cryopreserved Formulation of OTL-103 in Subjects With Wiskott-Aldrich Syndrome

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03837483
Recruitment Status : Active, not recruiting
First Posted : February 12, 2019
Last Update Posted : December 8, 2020
Sponsor:
Collaborator:
Ospedale San Raffaele
Information provided by (Responsible Party):
Orchard Therapeutics

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Active, not recruiting
Estimated Primary Completion Date : February 2022
Estimated Study Completion Date : December 2022